Ingen internetforbindelse — viser den gemte version af siden.

Atara Biotherapeu…

USUSD
← Til screeneren

Atara Biotherapeutics Inc (LSE:0HIY) — Biotechnology: Biological Products (No Diagnostic Substances). Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
atarabio.com
Investorrelationer
investors.atarabio.com/news-events/press-releases
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Hovedkontor
South San Francisco, United States
Administrerende direktør
Anhco Nguyen
Ansatte
10
Grundlagt
2012
Børsnoteret siden
29.01.2018 (LSE:0HIY)
Udestående aktier
10.04 mio. pr. 2026-08-10
Free float
4.62 mio.
Markedsværdi
95.16 mio. USD
Insidere
16.8%
Institutionelle investorer
57.67%
Branche (SIC)
Biological Products, (No Diagnostic Substances)
LEI
549300WBXUXZRE03MS38
FCF
−50.9 mio. USD
Gæld
0
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksATRA primærUSD9.23 -1.49%almindelige aktier
LSE London Stock Exchange0HIY IOBUSD9.01 +0.00%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Nyheder denne uge

Ingen nyheder i den sidste uge. Seneste nyheder: 30.09.2026.

annonce

Største ejere

EjerAndelAktierRapportdato
EcoR1 Capital, LLC15.46%1.55 mio.2026-06-30
CIONGOLI GREGORY AUSTIN…≈12.17%1.22 mio.2026-06-09
Adage Capital Partners G…8.47%850 0002026-06-30
Point72 Asset Management…6.85%687 7182026-06-30
Redmile Group, LLC4.4%441 7012026-06-30
Vanguard Capital Managem…2.46%247 0472026-06-30
Mackenzie Financial Corp…2.32%233 2492026-06-30
CHERRY BRIAN N (Director…≈1.66%166 4862026-09-04
VANGUARD INDEX FUNDS-Van…1.58%158 6462026-06-30
NGUYEN ANHCO T (Chief Ex…≈1.32%132 7752026-08-17
Blackrock Inc.0.84%84 4552026-06-30
VANGUARD INDEX FUNDS-Van…0.82%82 7582026-06-30
TOUCHON PASCAL (Director…≈0.78%77 9552025-06-10
Geode Capital Management…0.75%75 1282026-06-30
HYLLENGREN ERIC J (Chief…≈0.56%56 2312025-03-03
Staley Capital Advisers,…0.5%50 0002026-06-30
Vanguard Fiduciary Trust…0.43%43 0362026-06-30
Fidelity Concord Street…0.35%35 3922026-07-31
iShares Trust-iShares Mi…0.19%18 8242026-08-31
Varbl Insurance Prod. Fd…0.16%16 2382026-07-31
Fidelity Concord Street…0.11%11 1752026-07-31
Fidelity Concord Street…0.1%10 4792026-07-31
Fidelity Concord Street…0.05%4 6122026-07-31
VANGUARD Inst. INDEX Fd.…0.03%2 8442026-06-30
VANGUARD VALLEY FORGE FU…0.03%2 7992026-06-30
ADIUMENTUM CAPITAL FUND…——2025-05-16
ECOR1 CAPITAL, L.L.C. (B…——2026-05-07
PANACEA INNOVATION LTD (…——2026-05-07
PANACEA VENTURE (Benefic…——2025-11-28
REDMILE GROUP, L.L.C. (U…——2026-07-22